4//SEC Filing
Lamothe Jeffrey G. 4
Accession 0000950170-24-009003
CIK 0001671584other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 6:04 PM ET
Size
6.8 KB
Accession
0000950170-24-009003
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2024-01-28+1,833→ 28,337 total - Exercise/Conversion
Restricted Stock Unit
2024-01-28−1,833→ 0 total→ Common Stock (1,833 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679967
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 6:04 PM ET
- Size
- 6.8 KB